Derepression and Modulation of Plasminogen Activator in Human Cell Hybrids and Their Segregants

  • L. Larizza
  • M. L. Tenchini
  • E. Rampoldi
  • L. De Carli
  • M. Colombi
  • S. Barlati
Part of the NATO Advanced Science Institutes Series book series (NSSA, volume 57)


Cell fusion has proven to be an useful tool for studying the genetic control of neoplastic transformation and its modulation in vitro (for review see,1–4).


Plasminogen Activator Somatic Cell Hybrid Hybrid Line Hybrid Clone Cloning Efficiency 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    H. L. Ozer, and K. K. Jha, Malignancy and transformation: expression in somatic cell hybrids and variants, Adv. Cancer Res. 25: 53 (1977).CrossRefGoogle Scholar
  2. 2.
    G. Barski, and J. Belehradek Jr., Inheritance of malignancy in somatic cell hybrids, Somat. Cell Genet. 5: 897 (1979).CrossRefGoogle Scholar
  3. 3.
    H. Harris, Some thoughts about genetics, differentiation and malignancy, Somat. Cell Genet. 5: 923 (1979).CrossRefGoogle Scholar
  4. 4.
    E. Sidebottom, The analysis of malignancy by cell fusion, In vitro 16:77 (1980).CrossRefGoogle Scholar
  5. 5.
    L. Ossowski, J. C. Unkeless, A. Tobia, J. P. Quigley, D. B. Rifkin, and E. Reich, An enzymatic function associated with transformation of fibroblast by oncogenic viruses. II. Mam-malian fibroblasts cultures transformed by DNA and RNA tumor viruses, J. exp. Med. 137: 112 (1973).CrossRefGoogle Scholar
  6. 6.
    R. Pollack, R. Risser, S. Conlon, and D. Rifkin, Plasminogen activator production accompanies loss of anchorage regulation in transformation of primary rat embryo cells by simian virus 40, Proc. nat. Acad. Sci. (Wash.) 71: 4792 (1974).CrossRefGoogle Scholar
  7. 7.
    P. A. Jones, J. S. Rhim, and H. Isaacs, The relationship between tumorigenicity, growth in agar and fibrinolytic activity in a line of human osteosarcoma cells. Int. J. Cancer 16: 616 (1975).CrossRefGoogle Scholar
  8. 8.
    W. E. Laug, P. A. Jones, and W. Benedict, Relationship between fibrinolysis of cultured cells and malignancy, J. nat. Cancer Inst. 54: 173 (1975).Google Scholar
  9. 9.
    J. C. Barrett, S. Sheela, 0. Kazunori, and T. Kakunaga, Reexamination of the role of plasminogen activator production for growth in semisolid agar of neoplastic hamster cells, Cancer Res. 40: 1438 (1980).Google Scholar
  10. 10.
    R. Davidson, and P. Gerald, Improved techniques for the induction of mammalian cell hybridization by polyethylene glycol. Somat. Cell Genet. 2: 165 (1976).CrossRefGoogle Scholar
  11. 11.
    L. Larizza, G. Simoni, M. Stefanini, and L. De Carli, Spontaneous and Griseofulvin induced segregation for 8-Azaguanine resistance in hybrids from a human heteroploid line. Exp. Cell Res. 120: 405 (1979).CrossRefGoogle Scholar
  12. 12.
    H. Saksela, Radial caseinolysis in agarose: a simple method for detection of plasminogen activator in the presence of inhibitory substances and serum. Analytical Biochemistry 111: 276 (1981).CrossRefGoogle Scholar
  13. 13.
    I. MacPherson, and L. Montagnier, Agar suspension culture for the selective assay of cells transformed by polyoma virus. Virology 23: 291 (1964).CrossRefGoogle Scholar
  14. 14.
    L. Larizza, M. L. Tenchini, A. Mottura, E. Rampoldi, M. Colombi, and S. Barlati, Expression of fibronectin and plasminogen activator in human cell hybrids, in “Protides of the Biolo-gical Fluids”, Pergamon Press, in press.Google Scholar
  15. 15.
    K. K. Jha, J. Cacciapuoti, and H. L. Ozer, Expression of transformation in cell hybrids. II. Non suppression of the trans-formed phenotype in hybrids between a chemically transformed and nontransformed derivatives of BALB/3T3, J. Cell. Physiol. 97: 147 (1978).CrossRefGoogle Scholar
  16. 16.
    E. J. Stanbridge, and J. Wilkinson, Analysis of malignancy in human cells: malignant and transformed phenotypes are under separate genetic control, Proc. nat. Acad. Sci. (Wash.) 75: 1466 (1978).CrossRefGoogle Scholar
  17. 17.
    D. S. Straus, J. Jonasson, and H. Harris, Growth in vitro of tumor cell x fibroblast hybrids in which malignancy is suppressed, J. Cell Sci. 25: 73 (1977).Google Scholar
  18. 18.
    R. Kuckerlapati, R. Tepper, A. Granelli-Piperno, and E. Reich, Modulation and mapping of a human plasminogen activator by cell fusion, Cell 15: 1331 (1978).CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1983

Authors and Affiliations

  • L. Larizza
    • 1
  • M. L. Tenchini
    • 1
  • E. Rampoldi
    • 1
  • L. De Carli
    • 2
  • M. Colombi
    • 3
  • S. Barlati
    • 3
  1. 1.Istituto di Biologia Generale, Faculty of MedicineUniv. of MilanItaly
  2. 2.Istituto di GeneticaUniv. of PaviaItaly
  3. 3.Istituto di Genetica Bioch. ed Evol.CNRPaviaItaly

Personalised recommendations